Ovarian Cancer Research Alliance (OCRA) congratulates board member Laura Shawver, PhD, on her selection to the Fierce 50 of 2025, a leading industry award from Fierce Life Sciences recognizing individuals and organizations advancing what’s possible in health, science and patient care.
Dr. Shawver was selected for her long-standing leadership in oncology research and drug development, recognition that reflects her influence in advancing scientific innovation and shaping progress in the biopharma industry. She is an ovarian cancer survivor and the founder of The Clearity Foundation, which joined the OCRA family in January 2025.
The Fierce 50 award was accepted on her behalf by Audra Moran, OCRA’s President and CEO.
Dr. Shawver’s recognition underscores the importance of scientific leadership, evidence-based innovation, and patient-centered progress—core values that drive OCRA’s work to improve prevention, treatment options, and long-term survival for those affected by ovarian and gynecologic cancers.
OCRA congratulates Dr. Shawver on this well-deserved honor and celebrates her continued contributions to the field.
